Turkey
Change Language:
Gilead Sciences İlaç Tic Ltd Sti
AND Kozyatagi
Icerenkoy Mahallesi
Umut Sokak 10-12 Atasehir Istanbul
Turkey
Phone: 216 559 0300 216 559 0300
Fax: 90-212-362-03-01
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.
Established in 2007, Gilead’s office in Istanbul is responsible for registering, importing, marketing, sales and distribution of our products in Turkey.
Relationships with Patient Organizations
Gilead provided support for the following patient organizations in 2018. The information is correct at the time of writing (March 2019). The information is subject to change and periodic updates. For a listing of previous years’ payments, click here.
| Patient Organisation Recipient | Description of Activity | Amount Funded TRL |
|---|---|---|
| Kırmızı Şemsiye Cinsel Sağlık ve İnsan Hakları Derneği, Ankara | Fellowship Grant for Improvement of Sexual Health Status of Sex Workers in various locations in Turkey project | 68600 |
| Pozitif-iz Derneği | Fellowship Grant for Peer Consultancy, Capacity Building and Advocacy Trainings Project | 58100 |
| KIRMIZI KURDELE İSTANBUL DERNEĞI | Grant for "Training Academy Turkey" Project | 149017,6 |
| POZİTİF YAŞAM DERNEĞİ | Participation to "HIV&AIDS Awareness Advisory Board" | 780 |
| POZİTİF-İZ DERNEĞİ | Participation to "HIV&AIDS Awareness Advisory Board" | 780 |
| SAĞLIKTA GENÇ YAKLAŞIMLAR DERNEĞİ | Participation to "HIV&AIDS Awareness Advisory Board" | 780 |
| KIRMIZI ŞEMSİYE CİNSEL SAĞLIK VE İNSAN HAKLARI DERNEĞİ | Participation to "HIV&AIDS Awareness Advisory Board" | 780 |
| SOSYAL POLİTİKALAR CİNSİYET KİMLİĞİ VE CİNSEL YÖNELİM ÇALIŞMALARI DERNEĞİ (SPOD) | Participation to "HIV&AIDS Awareness Advisory Board" | 780 |
| KAOS GEY VE LEZBİYEN KÜLTÜREL ARAŞTIRMA VE DAYANIŞMA DERNEĞİ | Participation to "HIV&AIDS Awareness Advisory Board" | 780 |
This page is intended for visitors outside of the United States.